McKesson Corporation Enters Agreement to Sell Certain European Businesses to the PHOENIX Group

Transaction enhances McKesson’s focus and commitment to future investments in strategic growth, including oncology and biopharma services, and core pharmaceutical and medical distribution Agreement includes the sale of McKesson Europe […]

GAF Announces the Acquisition of Icopal

GAF, North America’s largest roofing manufacturer, announced today that it has entered into a definitive agreement to acquire Icopal (“the Company”), a leading pan-European manufacturer of roofing and other waterproofing products, from Investcorp Ltd for approximately €1 billion. The transaction, which builds upon GAF’s market-leading products by adding a portfolio of high-quality brands in Europe and the United States, will create the world’s pre-eminent roofing company. The acquisition is expected to close by the second quarter of 2016.

First Marketing Authorizations in Europe for IQYMUNE®, LFB’s 10% Liquid Intravenous Immunoglobulin

LFB SA announces the first two marketing authorizations for its 10% liquid intravenous immunoglobulin (IVIg) in Europe, namely in the United Kingdom and in Denmark. Thirteen more national marketing authorizations in Europe are expected in the coming months. Simultaneously to this ongoing European decentralized procedure, registrations are to take place in 33 countries in rest of the world, for launches staggered between 2016 and 2020.

Ecolab’s Apex Warewashing System Helps Restaurant and Foodservice Operators Throughout Europe Improve Results, Save Water and Energy

Ecolab Inc., the global leader in water, hygiene and energy technologies and services, has launched Apex, a warewashing system that will provide the cleaning results restaurant and foodservice operators throughout Europe expect, while reducing water and energy use.

Agilent Technologies Completes Acquisition of Dako, Danish Cancer Diagnostics Company

Agilent Technologies Inc. (NYSE:A) today announced that its acquisition of cancer diagnostics company Dako has been completed. Agilent, which paid $2.2 billion in cash for Dako (on a debt-free basis), expects the acquisition to help strengthen Agilents position in life sciences, with a focus on product development to help in the fight against cancer.